Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 60,151 | 60,115 | 73,371 | 82,503 | 87,643 |
| Cost of Goods | 11,277 | 9,370 | 12,104 | 21,280 | 16,696 |
| Gross Profit | 48,874 | 50,745 | 61,267 | 61,223 | 70,947 |
| Operating Expenses | 93,164 | 132,040 | 100,918 | 94,290 | 95,807 |
| Operating Income | -44,013 | -80,925 | -39,547 | -32,787 | -24,164 |
| Interest Expense | 6,580 | 8,969 | 5,793 | 5,771 | 5,747 |
| Other Income | 443 | -6,190 | -385 | 30 | 11 |
| Pre-tax Income | -50,150 | -96,084 | -45,725 | -38,528 | -29,900 |
| Net Income Continuous | -50,150 | -96,084 | -45,725 | -38,528 | -29,900 |
| Net Income | $-50,150 | $-96,084 | $-45,725 | $-38,528 | $-29,900 |
| EPS Basic Total Ops | -0.65 | -1.24 | -0.55 | -0.49 | -0.40 |
| EPS Basic Continuous Ops | -0.65 | -1.24 | -0.55 | -0.49 | -0.40 |
| EPS Diluted Total Ops | -0.65 | -1.24 | -0.55 | -0.49 | -0.40 |
| EPS Diluted Continuous Ops | -0.65 | -1.24 | -0.55 | -0.49 | -0.40 |
| EBITDA(a) | $-43,126 | $-80,158 | $-38,711 | $-31,895 | $-23,287 |